Wounds Can Smell Awful. This Revolutionary Cinnamon-Based Solution Can Help.
Wound Malodors Are Common. Cinesteam®'s Cinnamon Secondary Dressings Are Scientifically Proven to Effectively Improve Patient Quality of Life.
"Cinnamon is a natural spice with incredible olfactory capabilities," says
The studies in reference were based on sensory analysis and odor quantification and used laboratory-based chromatographic analysis. During in vitro analysis, participants were asked to characterize necrotic odors that ranged from unpleasant to very pleasant using different spices as well as charcoal.
In the end, cinnamon stood out as a substance that could reduce unwanted VOCs at an efficiency similar to charcoal, which is known for its filtration properties. Critically, cinnamon was also able to emit pleasant VOCs into the air — something that charcoal cannot do.
Armed with this information, Desjardin and the Cinesteam® team developed a revolutionary secondary dressing that used layered technology, including an absorbent core and a sachet filled with cinnamon powder. Prototypes of the product were used on a small sample of patients with 83% reporting that the odors were not just reduced but completely eliminated.
In the years since their inception, Cinesteam® dressings have become available to the public. They are empowering patients and caregivers across the globe by helping them manage malodors in a safe and effective manner.
About Cinesteam®:
Cinesteam® is a brand owned by a French pharmaceutical company based in
Media Contact:
Clémence DESJARDIN, PhD
Business Development Manager
55 rue de Turbigo – 75003 Paris –
Tel : +33 (0) 1 86 22 02 22
Mob: +33 (0) 6 63 04 32 77
Fax : +33 (0)1 73 79 35 54
email : [email protected]
View original content:https://www.prnewswire.com/news-releases/wounds-can-smell-awful-this-revolutionary-cinnamon-based-solution-can-help-302236993.html
SOURCE Cinesteam
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPENGA Rejoins Franchise FastLane's FastLane Program to Fuel Next Phase of Growth
- NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
- "I AM ME: A Rhyming Book About Being Autistic and Biracial," a Rhyming Book with a Powerful Message
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share